Utilization of model-agnostic explainable artificial intelligence frameworks in oncology: a narrative review.
Utilization of model-agnostic explainable artificial intelligence frameworks in oncology: a narrative review.
复制标题
DOI:
10.21037/tcr-22-1626
复制
发表时间:
2022-10
影响因子:
0.9
通讯作者:
中科院分区:
文献类型:
--
作者:
Machine learning (ML) models are increasingly being utilized in oncology research for use in the clinic. However, while more complicated models may provide improvements in predictive or prognostic power, a hurdle to their adoption are limits of model interpretability, wherein the inner workings can be perceived as a “black box”. Explainable artificial intelligence (XAI) frameworks including Local Interpretable Model-agnostic Explanations (LIME) and SHapley Additive exPlanations (SHAP) are novel, model-agnostic approaches that aim to provide insight into the inner workings of the “black box” by producing quantitative visualizations of how model predictions are calculated. In doing so, XAI can transform complicated ML models into easily understandable charts and interpretable sets of rules, which can give providers with an intuitive understanding of the knowledge generated, thus facilitating the deployment of such models in routine clinical workflows. We performed a comprehensive, non-systematic review of the latest literature to define use cases of model-agnostic XAI frameworks in oncologic research. The examined database was PubMed/MEDLINE. The last search was run on May 1, 2022. In this review, we identified several fields in oncology research where ML models and XAI were utilized to improve interpretability, including prognostication, diagnosis, radiomics, pathology, treatment selection, radiation treatment workflows, and epidemiology. Within these fields, XAI facilitates determination of feature importance in the overall model, visualization of relationships and/or interactions, evaluation of how individual predictions are produced, feature selection, identification of prognostic and/or predictive thresholds, and overall confidence in the models, among other benefits. These examples provide a basis for future work to expand on, which can facilitate adoption in the clinic when the complexity of such modeling would otherwise be prohibitive. Model-agnostic XAI frameworks offer an intuitive and effective means of describing oncology ML models, with applications including prognostication and determination of optimal treatment regimens. Using such frameworks presents an opportunity to improve understanding of ML models, which is a critical step to their adoption in the clinic.
登录
查看更多内容
影响因子:
--
作者:
通讯作者:
--
DOI:
10.1016/s1470-2045(18)30079-2
发表时间:
2018-03
期刊:
The Lancet. Oncology
影响因子:
--
作者:
de Boer SM;Powell ME;Mileshkin L;Katsaros D;Bessette P;Haie-Meder C;Ottevanger PB;Ledermann JA;Khaw P;Colombo A;Fyles A;Baron MH;Jürgenliemk-Schulz IM;Kitchener HC;Nijman HW;Wilson G;Brooks S;Carinelli S;Provencher D;Hanzen C;Lutgens LCHW;Smit VTHBM;Singh N;Do V;D'Amico R;Nout RA;Feeney A;Verhoeven-Adema KW;Putter H;Creutzberg CL;PORTEC study group
通讯作者:
PORTEC study group
影响因子:
3.5
作者:
Chen, Yunsheng;Aleman, Dionne M.;McIntosh, Chris
通讯作者:
McIntosh, Chris
影响因子:
2.4
作者:
Djulbegovic, Benjamin;Hozo, Iztok;Dale, William
通讯作者:
Dale, William
影响因子:
4.6
作者:
Alsinglawi B;Alshari O;Alorjani M;Mubin O;Alnajjar F;Novoa M;Darwish O
通讯作者:
Darwish O